0001567619-22-009494.txt : 20220504
0001567619-22-009494.hdr.sgml : 20220504
20220504120101
ACCESSION NUMBER: 0001567619-22-009494
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220429
FILED AS OF DATE: 20220504
DATE AS OF CHANGE: 20220504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis George Eric
CENTRAL INDEX KEY: 0001380710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 22890588
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2022-04-29
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001380710
Davis George Eric
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
EVP, Chief Legal Officer
Common Stock
2022-04-29
5
A
0
341
62.407
A
66339
D
Common Stock
2022-05-02
4
M
0
15347
37.46
A
81686
D
Common Stock
2022-05-02
4
S
0
15347
80.38
D
66339
D
Stock Option (Right to buy Common Stock)
37.46
2022-05-02
4
M
0
15347
0
D
2012-11-08
2022-05-07
Common Stock
15347
0
D
Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan.
Trade made pursuant to a 10b5-1 plan executed on March 4, 2022.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Eric Fleekop, Attorney-in-Fact
2022-05-04